JCTechnology LLC introduces Clario, a native iOS app that lets users ask anything about their finances in plain English ...
Clario, a leading provider of endpoint data solutions to the clinical trials industry, today announced that its artificial intelligence (AI) management system has been certified to the ISO 42001:2023 ...
Clinical trial tech company Clario has sealed its second acquisition in a week, doubling down further on neuroscience by picking up imaging specialist NeuroRx. NeuroRx founder and CEO Douglas Arnold, ...
Thermo Fisher Scientific, already a big player in providing services to the biopharmaceutical industry, is adding to its technology capabilities with the $9 billion acquisition of clinical trial ...
US-based clinical trial software company Clario has acquired WCG's electronic clinical outcome assessment (eCOA) business, having agreed to acquire it earlier this year. The acquisition aims to help ...
Clario's third annual ESG report for the calendar year 2023 highlights advancements in responsible artificial intelligence (AI), employee program investments, and ambitious science-based ...
Thermo Fisher (NYSE:TMO) is nearing a takeover of Clario in an all-cash deal that could value the clinical trial data management firm at around $10B, the Financial Times reported, citing people ...
Headquartered in Princeton, New Jersey, WCG is a provider of solutions that measurably improve and accelerate clinical research Dr. Chris Fikry serves as CEO of Clario and Sam Srivastava serves as CEO ...
Drug research is changing and there are opportunities for growth, says Christopher Fikry, the new CEO of clinical trial tech firm Clario. Fikry, who Clario named as its new chief last month, shared ...
In a major private equity buy-out deal, life science giant Thermo Fisher Scientific will pay up to $9.4bn cash to acquire drug trial data software company Clario. The acquisition will give ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results